A framework for monitoring of new drugs in Sweden.

A framework for monitoring of new drugs in Sweden.
Ups J Med Sci. 2019 Jan 28;:1-5
Authors: Cars T, Lindhagen L, Sundström J
Abstract
In order to monitor the net public health benefit of new drugs, especially in the light of recent stepwise approval approaches, there is a need to optimize real-time post-marketing evaluation of new drugs using data collected in routine care. Sweden, with its unique possibilities for observational research, can provide these data. We herein propose a framework for continuous monitoring of the effectiveness, safety, and cost-effectiveness of new drugs, using prospectively determined protocols designed in collaboration between all relevant stakeholders. We believe that this framework can be a useful tool for healthcare authorities and reimbursement agencies in the introduction of new drugs.
PMID: 30689485 [PubMed - as supplied by publisher]

Source: Upsala Journal of Medical Sciences - January 28, 2019 Category: General Medicine Authors: Cars T, Lindhagen L, Sundström J Tags: Ups J Med Sci Source Type: research